JPS63185970A - 2h-1,4-benzoxazin-3(4h)-one derivative - Google Patents
2h-1,4-benzoxazin-3(4h)-one derivativeInfo
- Publication number
- JPS63185970A JPS63185970A JP1437987A JP1437987A JPS63185970A JP S63185970 A JPS63185970 A JP S63185970A JP 1437987 A JP1437987 A JP 1437987A JP 1437987 A JP1437987 A JP 1437987A JP S63185970 A JPS63185970 A JP S63185970A
- Authority
- JP
- Japan
- Prior art keywords
- iodo
- group
- formula
- benzoxazin
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- QRCGFTXRXYMJOS-UHFFFAOYSA-N 4h-1,4-benzoxazin-3-one Chemical class C1=CC=C2NC(=O)COC2=C1 QRCGFTXRXYMJOS-UHFFFAOYSA-N 0.000 title abstract description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- -1 3-iodo-2-propynyloxy Chemical group 0.000 claims abstract description 12
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract description 4
- 230000000843 anti-fungal effect Effects 0.000 abstract description 4
- 229910052740 iodine Inorganic materials 0.000 abstract description 4
- 239000011630 iodine Substances 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- JGCCLOGJTCAPHK-UHFFFAOYSA-N 3-bromo-1-iodoprop-1-yne Chemical compound BrCC#CI JGCCLOGJTCAPHK-UHFFFAOYSA-N 0.000 abstract description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 201000009862 superficial mycosis Diseases 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- OSWXOBFCPGUBGC-UHFFFAOYSA-N 4-prop-2-ynyl-1,4-benzoxazin-3-one Chemical compound C1=CC=C2N(CC#C)C(=O)COC2=C1 OSWXOBFCPGUBGC-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ICCYFVWQNFMENX-UHFFFAOYSA-N 2-chloro-6-nitrophenol Chemical compound OC1=C(Cl)C=CC=C1[N+]([O-])=O ICCYFVWQNFMENX-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- WSYPKJIPQMYNKZ-UHFFFAOYSA-N 8-chloro-4-hydroxy-1,4-benzoxazin-3-one Chemical compound C1=CC=C2N(O)C(=O)COC2=C1Cl WSYPKJIPQMYNKZ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000893451 Arthroderma Species 0.000 description 1
- 241000112853 Arthrodes Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- ULWPSRBTOBHBKT-UHFFFAOYSA-N ethyl 2-(2-nitrophenoxy)acetate Chemical compound CCOC(=O)COC1=CC=CC=C1[N+]([O-])=O ULWPSRBTOBHBKT-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、極めて強い抗真菌活性を有し、表在性真菌症
の治療並びに予防に有用な2H−1,4−ベンズオキサ
ジン−3(4H)−オン誘導体に関するものである。Detailed Description of the Invention [Industrial Application Field] The present invention provides 2H-1,4-benzoxazine-3 ( 4H)-one derivatives.
3−ヨード−2−プロピニル基を有するへロブロジン(
下記構造式で示される化合物)は、強力な抗真菌活性を
有し、水虫治療薬として臨床に供されている。Herobrodin with 3-iodo-2-propynyl group (
The compound represented by the following structural formula) has strong antifungal activity and is used clinically as a treatment for athlete's foot.
本発明者らは、3−ヨード−2−プロピニル基を有する
化合物を種々合成しその抗真菌活性を調べたところ、前
記ハロプロジンよりも・高い活性を示す一連の化合物を
見出し、本発明を完成した。The present inventors synthesized various compounds having a 3-iodo-2-propynyl group and investigated their antifungal activity, and found a series of compounds exhibiting higher activity than the above-mentioned haloprozin, and completed the present invention. did.
〔問題点を解決するための手段、及び作用〕本発明は、
下記一般式(1)で表される化合物に係わる。[Means and effects for solving the problems] The present invention has the following features:
It relates to a compound represented by the following general formula (1).
■
〔式中、R1は3−ヨード−2−プロピニルオキシ基又
は3−ヨード−2−プロピニル基を示す。(2) [In the formula, R1 represents a 3-iodo-2-propynyloxy group or a 3-iodo-2-propynyl group.
R2は水素原子、ハロゲン原子、低級アルキル基、アシ
ルオキシ基又はニトロ基を示す。〕一般式(1)におい
て、Rzに関し具体的には、水素原子、フッ素原子、塩
素原子、臭素原子、ヨウ素原子、メチル基、エチル基、
プロピル基、イソプロピル基、ブチル基、イソブチル5
.5ee−ブチル基、tert−ブチル基、アセチルオ
キシ基、プロピオニルオキシ基、ベンゾイルオキシ基、
ニド四基等を例示できる。R2 represents a hydrogen atom, a halogen atom, a lower alkyl group, an acyloxy group or a nitro group. ] In general formula (1), Rz specifically includes a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, a methyl group, an ethyl group,
Propyl group, isopropyl group, butyl group, isobutyl 5
.. 5ee-butyl group, tert-butyl group, acetyloxy group, propionyloxy group, benzoyloxy group,
Examples include four Nido groups.
本発明化合物は、以下に示す〔反応式−1及び2〕の方
法より容易に製造できる。The compounds of the present invention can be easily produced by the methods shown in [Reaction Formulas-1 and 2] below.
〔反応式−1〕
([〕[1,)
C式中、R1は前記と同じ意義を示す。〕すなわち、本
発明化合物〔■、〕は、化合物(mに3−ブロム−1−
ヨード−1−プロピン〔ジャーナル・オブ・ザ・アメリ
カン・ケミカル9ソサイエテ4 (Journal o
f the llwerican Chem−ical
5ociety)、 77 @、 176 (195
5) )を反応させることにより製造することができる
。この反応は溶媒中塩基の存在下に行われる0本反応に
用いられる溶媒としては、例えばテトラヒドロフラン、
ジオキサン、アセトニトリル、N、N−ジメチルホルム
アミド等が好ましい、また、塩基としては、例えば水・
酸化カリウム、水酸化ナトリウム、水素化ナトリウム等
の無機塩基が好適である。[Reaction formula-1] ([][1,) In formula C, R1 has the same meaning as above. ] That is, the compound of the present invention [■,] is a compound (3-bromo-1-
Iodo-1-propyne [Journal of the American Chemical Society 4 (Journal o
f the llwerican chemical
5ociety), 77 @, 176 (195
5) It can be produced by reacting . This reaction is carried out in the presence of a base in a solvent. Examples of solvents used in this reaction include tetrahydrofuran,
Dioxane, acetonitrile, N,N-dimethylformamide, etc. are preferable, and as the base, for example, water,
Inorganic bases such as potassium oxide, sodium hydroxide, sodium hydride and the like are preferred.
本反応は、−10〜100℃、とりわけ0℃〜室温下で
行うのがよい0反応時間は5分〜10時間、好ましくは
5分〜2時間である。化合物〔II〕と3−ブロム−1
−ヨード−1−プロピンの使用割合に関しては、通常前
者に対して後者を1〜1.5倍モル使用する。This reaction is preferably carried out at -10 to 100°C, particularly from 0°C to room temperature, with a reaction time of 5 minutes to 10 hours, preferably 5 minutes to 2 hours. Compound [II] and 3-bromo-1
Regarding the usage ratio of -iodo-1-propyne, the latter is usually used in a molar range of 1 to 1.5 times that of the former.
(反応式−2〕
(11[] [b’1〔式中、
“R2は前記と同じ意義を示す。〕また、上記本発明化
合物(Ib )は、化合物([1)に塩基の存在下、ヨ
ウ素を反応させることによって製造することができる。(Reaction formula-2) (11 [] [b'1 [in the formula,
"R2 has the same meaning as above." Furthermore, the above-mentioned compound (Ib) of the present invention can be produced by reacting compound ([1) with iodine in the presence of a base.
塩基としては、例えば、水酸化カリウム、水酸化ナトリ
ウム等の無機塩基が挙げられる0反応は、通常、アルコ
ールと水の混合溶媒中で行われる。用いられるアルコー
ルとしては、例えばメタノール、エタノール、プロパツ
ール等が挙げられる0反応温度は0〜50℃、好ましく
はθ℃〜室温下において行われ、反応時間は2〜24時
間であるが、好ましくは2〜12時間である。化合物(
III )とヨウ素の使用割合に関しては、前者に対し
て後者を1〜1.5倍モル、好ましくは等モル使用する
のがよい。Examples of the base include inorganic bases such as potassium hydroxide and sodium hydroxide. The reaction is usually carried out in a mixed solvent of alcohol and water. Examples of the alcohol used include methanol, ethanol, propatool, etc. The reaction temperature is 0 to 50°C, preferably θ°C to room temperature, and the reaction time is 2 to 24 hours, but preferably It is 2 to 12 hours. Compound(
Regarding the proportion of III) and iodine, it is preferable to use 1 to 1.5 times the mole of the former, preferably equimolar moles of the latter.
なお、前記〔反応式−1〕の化合物(II)は、例えば
、ベンゼン核に置換基R2(前記と同じ意義を示す)を
有する0−二トロフェノール誘導体とブロム酢酸エチル
を原料とし、ホンヵネン(トonkanen )等の方
法〔アクタ・ケミ力・スカンジナビ力(八cta Ch
emica 5candinavica )+ 14
巻。The compound (II) of [Reaction formula-1] can be prepared, for example, by using an 0-ditrophenol derivative having a substituent R2 (same meaning as above) on the benzene nucleus and ethyl bromoacetate as raw materials, and converting honkanene ( Methods such as acta, chemical forces, and Scandinavian forces (8 acta Ch.
emica 5candinavica)+14
roll.
1214 (1960))に準拠して得ることができる
。1214 (1960)).
また、前記〔反応式−2〕の化合物(III )は、下
記反応式に従って容易に製造できる。Moreover, the compound (III) of [Reaction formula-2] can be easily produced according to the following reaction formula.
(m ’ (V)(III
)
〔式中、R1は前記と同じ意義を示す。〕化合物(IV
)と塩化クロルアセチルとの反応は特開昭49−125
529に記載の方法に準拠し、化合物(V)と3−ブロ
ムプロピンとの反応は前記〔反応式−1〕と同様な条件
下で行えばよい。(m' (V) (III
) [In the formula, R1 has the same meaning as above. ] Compound (IV
) with chloroacetyl chloride is described in JP-A-49-125.
The reaction between compound (V) and 3-bromopropyne may be carried out under the same conditions as described in [Reaction Formula-1] above.
本発明化合物(1)は、強い抗真菌作用を示し、特に表
在性真菌症に対して有効である。したがって、通常、軟
膏剤、ゼリー剤、クリーム剤、粉末剤、溶液剤、乳液剤
あるいはスプレー剤等の外用製剤にして使用する。これ
らの製剤化に際し特に困難はなく、それぞれに適した賦
形剤を使用し、公知の方法に準拠して製剤化すればよい
、好ましい賦形剤としては、例えば、軟膏剤5ゼリー剤
及びクリーム剤の場合、動物性脂肪、植物性脂肪。The compound (1) of the present invention exhibits a strong antifungal effect and is particularly effective against superficial mycoses. Therefore, it is usually used in the form of external preparations such as ointments, jellies, creams, powders, solutions, emulsions, or sprays. There is no particular difficulty in formulating these formulations, and they can be formulated according to known methods using excipients suitable for each. Preferred excipients include ointments, jelly formulations, and creams. In the case of pharmaceuticals, animal fats and vegetable fats.
ロウ、パラフィン、R粉トラガカント、セルロース誘導
体、ポリエチレングリコール、シリコーン。Wax, paraffin, R powder tragacanth, cellulose derivatives, polyethylene glycol, silicone.
ベントナイト、シリカ、タルク、酸化亜鉛等が挙げられ
、粉末剤及びスプレー剤の場合、乳糖、タルク、シリカ
、水酸化アルミニウム、ケイ酸カルシウム、ポリアミド
粉末、噴射基剤としてのクロルフルオロ炭化水素等が挙
げられ、また、溶液剤及び乳液剤の場合は、水、エタノ
ール、イソプロピルアルコール、炭酸エチル、酢酸エチ
ル、ベンジルアルコール、ベンジルベンゾエート、プロ
ピレングリコール、1.3−ブチレングリコール。Examples include bentonite, silica, talc, zinc oxide, etc., and in the case of powders and sprays, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, chlorofluorohydrocarbon as a propellant base, etc. In the case of solutions and emulsions, water, ethanol, isopropyl alcohol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylene glycol.
N、N−ジメチルホルムアミド、綿実油、南京豆油、ト
ウモロコシ油、オリーブ油、グリセリン。N,N-dimethylformamide, cottonseed oil, bed bean oil, corn oil, olive oil, glycerin.
グリセリンホルマール、ポリエチレングリコール。Glycerin formal, polyethylene glycol.
ソルビトールの脂肪酸エステル等が挙げられる。Examples include fatty acid esters of sorbitol.
本発明化合物(1)の製剤中の濃度は、0. 1〜5重
量重量%間囲内が好ましい。The concentration of the compound (1) of the present invention in the preparation is 0. A range of 1 to 5% by weight is preferred.
〔実施例1〕
4−ヒドロキシ−211−1,4−ベンズオキサジン−
3(4H)−オン5.3gと水酸イーカリウム2.1g
をN、N−ジメチルホルムアミド64−に加え、よくか
きまぜたのち氷冷攪拌下3−ブロムー1=ヨード−1−
プロピン9.4gを滴下した。室温にて2時間攪拌後、
・溶媒を減圧留去した。得られた残渣に水を加え、析出
した結晶を濾取し、クロロホルム−石油エーテルから再
結晶して4− (3−ヨード−2−プロピニルオキシ)
−2H−1,4−ベンズオキサジン−3(4H)−オン
5.2g(収率49%)を得た。融点122〜123℃
。[Example 1] 4-hydroxy-211-1,4-benzoxazine-
5.3 g of 3(4H)-one and 2.1 g of e-potassium hydroxide
was added to N,N-dimethylformamide 64-, stirred well, and 3-bromo-1=iodo-1- was added to N,N-dimethylformamide 64-.
9.4 g of propyne was added dropwise. After stirring at room temperature for 2 hours,
- The solvent was distilled off under reduced pressure. Water was added to the resulting residue, the precipitated crystals were collected by filtration, and recrystallized from chloroform-petroleum ether to give 4-(3-iodo-2-propynyloxy).
5.2 g (yield 49%) of -2H-1,4-benzoxazin-3(4H)-one was obtained. Melting point 122-123℃
.
元素分析 : C++Hs lNOsとして理論値(
χ) : C,40,15i 11.2.45 ; N
、 4.26実測値(χ) : C,40,58i H
,2,70; N、 4.03I Ru Q9” cv
*−’ : 2180(C=C)、 1665(C−0
)N M R(DMSO−di)δ: 4.75 (2
H,s、0−CHz−GO)。Elemental analysis: Theoretical value as C++Hs lNOs (
χ): C, 40, 15i 11.2.45; N
, 4.26 Actual value (χ): C, 40, 58i H
,2,70; N, 4.03I Ru Q9” cv
*-': 2180 (C=C), 1665 (C-0
)NMR(DMSO-di)δ: 4.75 (2
H, s, 0-CHz-GO).
4.95 (2H,s、o−CHg−Cs*C)+ 6
.96〜7.30 (4tl、*、Ar−omatic
−H)
Mass (m/z):329 (M”)〔実施例2〕
8−クロル−4−ヒドロキシ−28−1,4−ベンズオ
キサジン−3(4H)−オン3.7gと3−ブロム−1
−ヨード−1−プロピン5.4gとを実施例1と同様に
反応させ、処理して8−クロル−4−(3−ヨード−2
−プロピニルオキシ)−2H−1,4−ベンズオキサジ
ン−3(4H)−オン4.5g (収率74%)を得た
。融点148〜150℃。4.95 (2H,s,o-CHg-Cs*C)+6
.. 96~7.30 (4tl, *, Ar-omatic
-H) Mass (m/z): 329 (M”) [Example 2] 3.7 g of 8-chloro-4-hydroxy-28-1,4-benzoxazin-3(4H)-one and 3-bromine -1
-Iodo-1-propyne (5.4 g) was reacted in the same manner as in Example 1, and treated with 8-chloro-4-(3-iodo-2-propylene).
4.5 g (yield: 74%) of -propynyloxy)-2H-1,4-benzoxazin-3(4H)-one was obtained. Melting point: 148-150°C.
元素分析 : C++H?CI I NOxとして理論
値(χ) : C,36,34; H,1,97; N
、 3.85実測値(χ) : C,36,39; H
,1,99; N、 3.86IRν易l朱” cm
−’ : 2180(C=C)、 1680(C−
0)N M R([1M5O−di)δ : 4.90
(2H,s、0−C11t−Co)。Elemental analysis: C++H? Theoretical value (χ) for CI I NOx: C, 36,34; H, 1,97; N
, 3.85 Actual value (χ): C, 36, 39; H
, 1,99;
-': 2180 (C=C), 1680 (C-
0)NMR([1M5O-di)δ: 4.90
(2H,s,0-C11t-Co).
4.97 (2H,3,0−CI+!−C=C)、 7
.20〜7.’30 (3H,n+、^r−omati
c−II)
Mass (m/z) :363 (M”)〔実
施例3〕
4−(2−プロピニル)−2H−1,4−ベンズオキサ
ジン−3(4H)−オン30gをメタノール320sd
と5N水酸化す) IJウム水溶液32−の混合溶液に
懸濁し、水冷撹拌下ヨウ素4067gを加えた。その後
室温にて12時間攪拌した。4.97 (2H,3,0-CI+!-C=C), 7
.. 20-7. '30 (3H, n+, ^r-omati
c-II) Mass (m/z): 363 (M”) [Example 3] 30 g of 4-(2-propynyl)-2H-1,4-benzoxazin-3(4H)-one in 320 sd of methanol
and 5N hydroxide) was suspended in a mixed solution of 32% of an aqueous solution of iodine, and 4067 g of iodine was added thereto while stirring while cooling with water. Thereafter, the mixture was stirred at room temperature for 12 hours.
反応液を水中に注ぎクロロホルムで抽出した。抽出液を
チオ硫酸ナトリウム水溶液で洗浄、乾燥後溶媒を留去し
た。得られた結晶をクロロホルム−石油エーテルから・
再結晶して4−(3−ヨード−2−プロピニル)−2H
−1,4−ベンズオキサジン−3(4H)−オン20.
9g(収率42%)を得た。融点166〜171℃、′
元素分析 : C++Hs t Notとして理論値
(χ) : C,42,20i H,2゜58 ; N
、 4.47実測値(χ) : C,42,03、H,
2,6B 、 N、 4.27I Rv:gQ” c+
w−’ : 2180(CミC)、 1655(C=
O)N M R(DMSO−da)δ : 4.63
(2H,s、0−CHt−CO)。The reaction solution was poured into water and extracted with chloroform. The extract was washed with an aqueous sodium thiosulfate solution, dried, and then the solvent was distilled off. The obtained crystals were separated from chloroform-petroleum ether.
Recrystallize to give 4-(3-iodo-2-propynyl)-2H
-1,4-benzoxazin-3(4H)-one 20.
9 g (yield 42%) was obtained. Melting point 166-171℃,' Elemental analysis: C++Hs t Not theoretical value (χ): C, 42,20i H, 2゜58; N
, 4.47 Actual value (χ): C, 42,03, H,
2,6B, N, 4.27I Rv:gQ"c+
w-': 2180 (CmiC), 1655 (C=
O)NMR(DMSO-da)δ: 4.63
(2H,s,0-CHt-CO).
4.80 (211,s、O−C0−C1lミC)1
6.96〜7.28 (48,m、八r−omati
c−H)
Ma s s (m/ z) : 3 13
(M’ )〔実施例4〜15〕
対応原料化合物を実施例3と同様に処理して下記化合物
を得た。4.80 (211,s, O-C0-C1lmiC)1
6.96~7.28 (48, m, 8 r-omati
c-H) Mas s (m/z): 3 13
(M') [Examples 4 to 15] The corresponding raw material compounds were treated in the same manner as in Example 3 to obtain the following compounds.
〔参考例1〕
(a)N、N−ジメチルホルムアミド400adにO−
ニトロフェノール69.5g、ブロム酢酸エチル125
g及び炭酸カリウム104gを加え、80℃で2時間攪
拌したのち冷却した。不溶物を濾去後溶媒を減圧留去し
、残渣に水を加えクロロホルムで抽出した。抽出液を水
洗、乾燥後溶媒を留去し、さらに減圧薫留して0−ニト
ロフェノキシ酢酸エチル96g(収率85%)を得た。[Reference Example 1] (a) O- to N,N-dimethylformamide 400ad
Nitrophenol 69.5g, ethyl bromoacetate 125g
g and 104 g of potassium carbonate were added thereto, stirred at 80° C. for 2 hours, and then cooled. After filtering off the insoluble matter, the solvent was distilled off under reduced pressure, water was added to the residue, and the mixture was extracted with chloroform. After washing the extract with water and drying, the solvent was distilled off and further vacuum distilled to obtain 96 g of ethyl 0-nitrophenoxyacetate (yield: 85%).
沸点145〜146℃10.3mmHg。Boiling point: 145-146°C, 10.3 mmHg.
(b)o−ニトロフェノキシ酢酸エチル22.5g、エ
タノール10〇−及び亜鉛粉末15.2gを混合し、室
温にて攪拌しながら塩化アンモニウム6.2gを含む水
溶液20−を滴下した0滴下後さらに3時間攪拌したの
ち水冷下2.4N塩酸200mを滴下した。不溶物を濾
取し、エタノールから再結晶して4−ヒドロキシ−2H
−1,4−ベンズオキサジン−3(4H)−オン6.2
g (収率38%)を得た。融点168〜171℃。(b) 22.5 g of ethyl o-nitrophenoxyacetate, 100 g of ethanol, and 15.2 g of zinc powder were mixed, and 20 g of an aqueous solution containing 6.2 g of ammonium chloride was added dropwise while stirring at room temperature. After stirring for 3 hours, 200 ml of 2.4N hydrochloric acid was added dropwise while cooling with water. Insoluble materials were collected by filtration and recrystallized from ethanol to give 4-hydroxy-2H.
-1,4-benzoxazin-3(4H)-one 6.2
g (yield 38%) was obtained. Melting point 168-171°C.
〔参考例2〕
6−クロル−2−二トロフェノール及びブロム酢酸エチ
ルを原料として使用し、参考例1と同様に処理して8−
クロル−4−ヒドロキシ−2H−1,4−ベンズオキサ
ジン−3(4H)−オンを58%の収率で得た。融点2
23〜225℃。[Reference Example 2] Using 6-chloro-2-nitrophenol and ethyl bromoacetate as raw materials, the same procedure as in Reference Example 1 was used to obtain 8-
Chlor-4-hydroxy-2H-1,4-benzoxazin-3(4H)-one was obtained with a yield of 58%. Melting point 2
23-225°C.
〔参考例3〕
(a)o−アミノフェノールl1g、)リエチルアミン
15.5g及び酢酸エチル500−の混合溶液に、水冷
下、塩化クロルアセチル11.3gを滴下した。室温に
て2時間攪拌したのち反応液を水洗し、溶媒を留去した
。残渣に0.3N水酸化ナトリウム水溶液5(ladを
加え、80℃にて加熱熔解させ、析出した結晶をベンゼ
ンから再結晶して2H−1,4−ベンズオキサジン−3
(4H)−オン5.6g(収率38%)を得た。 融点
177〜178℃。[Reference Example 3] To a mixed solution of (a) 1 g of o-aminophenol, 15.5 g of ethylamine, and 500 g of ethyl acetate, 11.3 g of chloroacetyl chloride was added dropwise under water cooling. After stirring at room temperature for 2 hours, the reaction solution was washed with water and the solvent was distilled off. A 0.3N aqueous sodium hydroxide solution 5 (lad) was added to the residue, heated and melted at 80°C, and the precipitated crystals were recrystallized from benzene to give 2H-1,4-benzoxazine-3.
5.6 g (yield 38%) of (4H)-one was obtained. Melting point: 177-178°C.
(b)2H−1,4−ベンズオキサジン−3(4H)−
オン4.5g、水酸化カリウム2.0g及びN、N−ジ
メチルホルムアミド60−の混合物を室温にて1時間攪
拌したのち、水冷下3−ブロムプロピン7.1gを滴下
した。室温下さらに1時間攪拌し、溶媒を減圧留去後得
られた残渣に水を加え析出した結晶を濾取した。N、N
−ジメチルホルムアミド−イソプロピルエーテルから再
結晶して4−(2−プロピニル)−2H−1,4−ベン
ズオキサジン−3(4H)−オン 2.1g(収率37
%)を得た。融点123〜125℃。(b) 2H-1,4-benzoxazine-3(4H)-
After stirring a mixture of 4.5 g of onion, 2.0 g of potassium hydroxide, and 60 g of N,N-dimethylformamide at room temperature for 1 hour, 7.1 g of 3-bromopropyne was added dropwise while cooling with water. The mixture was further stirred at room temperature for 1 hour, and the solvent was distilled off under reduced pressure. Water was added to the resulting residue, and the precipitated crystals were collected by filtration. N, N
Recrystallization from -dimethylformamide-isopropyl ether gave 2.1 g of 4-(2-propynyl)-2H-1,4-benzoxazin-3(4H)-one (yield: 37
%) was obtained. Melting point 123-125°C.
〔参考例4〜15〕
対応原料化合物を参考例3と同様に処理して下記化合物
を得た。[Reference Examples 4 to 15] The corresponding raw material compounds were treated in the same manner as in Reference Example 3 to obtain the following compounds.
第 2 表
cHzc=cH
〔製剤例〕
実施例1の化合物 2.0g白色ワセリン
25.0gステアリルアルコール
25.0gプロピレングリコール 12.0
gラウリル硫酸ナトリウム 1.5gバラオキシ
安息香酸エチル 0.5gさらに脱イオン水を加え
て全量を100.0gとする。Table 2 cHzc=cH [Formulation example] Compound of Example 1 2.0g white petrolatum 25.0g stearyl alcohol
25.0g Propylene glycol 12.0
g Sodium lauryl sulfate 1.5 g Ethyl oxybenzoate 0.5 g Further, add deionized water to bring the total amount to 100.0 g.
上記混合物を常法に従って均一に混合し、クリーム剤と
した。The above mixture was uniformly mixed according to a conventional method to prepare a cream.
(1)各種真菌に対する最小発育阻止濃度(MIC)の
測定
サブローデキストロース培地を用い、日本化学療法学会
標準法(’1980年改訂)に準じて寒天平板希釈法に
よりMICを求めた。その結果を第3表に示す。(1) Measurement of Minimum Inhibitory Concentration (MIC) for Various Fungi Using Sabouraud dextrose medium, MIC was determined by the agar plate dilution method according to the standard method of the Japanese Society of Chemotherapy (revised in 1980). The results are shown in Table 3.
第3表 MIC(μg/−)
a)(1):カンジダ・アルビカンス(Candida
albicans ) I F O1060、(II
) :カンジダ・トロピカーリス(Candida t
ropicalis )IFO1633、(III)
j )リコフィートン・ルブラム(Trichoph
yton rubru+w) T R−37、(m :
アースロデルマ・パンブロイゼゲミー(Arthrod
ersa vanbreuseghes+ii) S
M 7420、(V): ミクロスポーラム・キャニ
ス(Micro−sporum cants) SM
8333 As b)試験せず。Table 3 MIC (μg/-) a) (1): Candida albicans (Candida albicans)
albicans) I F O1060, (II
): Candida tropicalis (Candida t
ropicalis) IFO1633, (III)
j) Trichophyton Rubrum (Trichoph)
yton rubru+w) TR-37, (m:
Arthroderma pambrosegemie (Arthrod)
ersa vanbreuseghes+ii) S
M 7420, (V): Micro-sporum cants SM
8333 As b) Not tested.
(2)急性毒性試験
被検化合物を0.5%カルボキシメチルセルロース溶液
に懸濁し、体重20〜25gのDDY系雄性マウス(1
群lO匹)に経口投与して、投与後7日間の累積死亡率
から50%致死量(LDs。)を算出した。結果を第4
表に示す。(2) Acute toxicity test The test compound was suspended in 0.5% carboxymethyl cellulose solution, and DDY male mice weighing 20-25 g (1
The 50% lethal dose (LDs.) was calculated from the cumulative mortality rate for 7 days after administration. 4th result
Shown in the table.
第4表
(発明の効果〕
本発明化合物は各種真菌に対するMIC測定実験におい
て優れた活性を示し、また、動物実験において毒性が低
いことが確認された。Table 4 (Effects of the Invention) The compounds of the present invention showed excellent activity in MIC measurement experiments against various fungi, and were also confirmed to have low toxicity in animal experiments.
本発明化合物は、抗真凹薬として優れた効果を特徴するThe compound of the present invention is characterized by excellent effects as an anti-depressant drug.
Claims (3)
又は3−ヨード−2−プロピニル基を示す。 R^2は水素原子、ハロゲン原子、低級アルキル基、ア
シルオキシ基又はニトロ基を示す。〕で表される2H−
1,4−ベンズオキサンソ−3(4H)−オン誘導体。(1) General formula [I] ▲Mathematical formulas, chemical formulas, tables, etc.▼[I] [In the formula, R^1 represents a 3-iodo-2-propynyloxy group or a 3-iodo-2-propynyl group. R^2 represents a hydrogen atom, a halogen atom, a lower alkyl group, an acyloxy group, or a nitro group. ] 2H-
1,4-benzoxanth-3(4H)-one derivative.
2−プロピニルオキシ基で表される特許請求の範囲第1
項記載の化合物。(2) In the general formula [I], R^1 is 3-iodo-
Claim 1 represented by 2-propynyloxy group
Compounds described in Section.
2−プロピニル基で表される特許請求の範囲第1項記載
の化合物。(3) In the general formula [I], R^1 is 3-iodo-
The compound according to claim 1, which is represented by a 2-propynyl group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1437987A JPS63185970A (en) | 1987-01-23 | 1987-01-23 | 2h-1,4-benzoxazin-3(4h)-one derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1437987A JPS63185970A (en) | 1987-01-23 | 1987-01-23 | 2h-1,4-benzoxazin-3(4h)-one derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63185970A true JPS63185970A (en) | 1988-08-01 |
Family
ID=11859409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1437987A Pending JPS63185970A (en) | 1987-01-23 | 1987-01-23 | 2h-1,4-benzoxazin-3(4h)-one derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63185970A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008012385A1 (en) | 2006-07-28 | 2008-01-31 | Universidad De Cádiz | Phytotoxic halogenated derivatives of benzoxazinones |
-
1987
- 1987-01-23 JP JP1437987A patent/JPS63185970A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008012385A1 (en) | 2006-07-28 | 2008-01-31 | Universidad De Cádiz | Phytotoxic halogenated derivatives of benzoxazinones |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU194839B (en) | Process for production of derivatives of triasole and imidasole and medical preparatives containing such compounds | |
LU85245A1 (en) | NOVEL AZOLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIFUNGALS AND FUNGICIDES | |
EP0243904A1 (en) | Optionally substituted 1-(2'-[bis-(phenyl)-methoxy]-ethyl)-4-(3'[bis-(phenyl)-methoxy]propyl)piperazines, process for their preparation and medicines containing them | |
JPS6033818B2 (en) | Manufacturing method for new naphthalene derivatives | |
EP0010361B1 (en) | Bis-imidazoles, their preparation and pharmaceutical compositions containing them | |
EP0490816B1 (en) | Fluoro-compounds and their use as aromatase inhibitors | |
JPH01294670A (en) | 2-(piperadinyl)-2-oxoethylene-substituted flavonoid derivative, its production and pharmaceutical composition containing said derivative | |
EP0006789A1 (en) | Bis(aryloxy-alcanecarboxylic compounds, their preparation and their therapeutic use | |
HU195502B (en) | Process for producing triazol derivatives of fungicide activity and pharmaceutical compositions containing them | |
JPS63185970A (en) | 2h-1,4-benzoxazin-3(4h)-one derivative | |
PL103682B1 (en) | METHOD OF MAKING NEW DERIVATIVES OF INDAZOLYLOXY-4-PROPANOLOAMINE | |
US3418355A (en) | Didecyl quaternary ammonium compounds | |
JPS62281860A (en) | Dihydro-3,5-dicarboxylate having alkyleneaminoalkyleneheteroatomic group | |
KR970011395B1 (en) | Enol ethers of 6-chloro-4-hydroxy-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1.2-thiazine-3-carboxamide 1,1-dioxide | |
JPS6344749B2 (en) | ||
JPH0288566A (en) | Diphenylethane derivative, its production, and aromatase inhibiting drug and veterinary composition containing the same | |
DD146823A5 (en) | PROCESS FOR PREPARING AMINO-PROPANOL DERIVATIVES OF 6-HYDROXY-2,3,4,5-TETRAHYDRO-1 H-1-BENZAZEPIN-2-ONE | |
EP0000693A1 (en) | Aminophenoxymethyl-2-morpholine derivatives, the preparation thereof and pharmaceuticals containing them | |
JPH0372221B2 (en) | ||
JPH0353314B2 (en) | ||
EP0182271B1 (en) | Nb-quaternary dibromo derivatives of ajmaline, isoajmaline, sandwicine and isosandwicine, pharmaceutical compositions containing them, intermediates and process for their preparation | |
HU209302B (en) | Method for producing dihydro-benzo-(b)-thiphenes and pharmaceutical preparatives containing these compounds | |
HU189439B (en) | Process for producing triazol compounds | |
EP0647221A1 (en) | 1-aryl(4-o-alkoxyphenyl 1-piperazinyl)-2, -3 or -4 alkanols, process for their preparation and use thereof in the preparation of drugs | |
JPS59128326A (en) | Antieumycetic agent |